A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the woodruff variant of coxsackievirus B3

Journal of Virology

Volumn 70, Issue 11, 1996, Pages 7811-7818

  Knowlton, Kirk U ^a   Jeon, Eun Seok ^a   Berkley, Neil ^a   Wessely, Rainer ^a   Huber, Sally ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ASPARAGINE; ASPARTIC ACID; COMPLEMENTARY DNA; GUANINE; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMOSOME PUFF; CONTROLLED STUDY; COXSACKIE VIRUS B3; MACROPHAGE; MALE; MOLECULAR CLONING; MONOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; VIRUS ATTENUATION; VIRUS GENOME; VIRUS MYOCARDITIS; VIRUS TYPING;

EID: 0029843593     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.11.7811-7818.1996     Document Type: Article

References (48)

1. Almond, J. W. 1987. The attenuation of poliovirus neurovirulence. Annu. Rev. Microhiol. 41:153-180.
2. Bergelson, J. M., J. G. Mohanty, R. L. Crowell, N. F. St. John, D. M. Lublin, and R. W. Finberg. 1995. Coxsackievirus B3 adapted to growth in RD cells hinds to decay-accelerating factor (CD55). J. Virol. 69:1903-1906.
3. Borrow, P., C. F. Evans, and M. B. Oldstone. 1995. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J. Virol. 69:1059-1070.
4. Caggana, M., P. Chan, and A. Ramsingh. 1993. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:4797-4803.
5. Chapman, N. M., Z. Tu, S. Tracy, and C. J. Gauntl. 1994. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses. Arch. Virol. 135:115-130.
6. Chow, L. H., K. W. Beisel, and B. M. McManus. 1992. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury. Lab. Invest. 66:24-31.
7. Chow, L. H., C. J. Gauntt, and B.M. McManus. 1991. Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice. A pathologic characterization of heart tissue damage. Lab. Invest. 64:55-64.
8. Fitch, F. W., M. D. McKisic, D. W. Lancki, and T. F. Gajewski. 1993. Differenlial regulation of murine T lymphocyte subsets. Annu. Rev. Immunol. 11:29-48.
9. Grun, J. B., M. Schultz, S. D. Finkelstein, R. L. Crowell, and B. J. Landau. 1988. Pathogenesis of acute myocardial necrosis in inbred mice infected with coxsackievirus B3. Microb. Pathog. 4:417-430.
10. Hamrell, B. B., S. A. Huber, and K. O. Leslie. 1994. Reduced unloaded sarcomere shortening velocity and a shift to a slower myosin isoform in acute murine coxsackievirus myocarditis. Circ. Res. 75:462-472.
11. Hogle, J. M., M. Chow, and D. J. Filman. 1985. Three-dimensional structure of poliovirus at 2.9 Å resolution. Science 229:1358-1365.
12. Huber, S. A., C. Haisch, and P. A. Lodge. 1990. Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J. Virol. 64:4516-4522.
13. Huber, S. A. Unpublished data.
14. Huber, S. A., and P. A. Lodge. 1984. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. Am. J. Pathol. 116: 21-29.
15. Huber, S. A., A. Moraska, and M. Choate. 1992. T cells expressing the γδ T-cell receptor potentiate coxsackievirus B3-induced myocarditis. J. Virol. 66:6541-6546.
16. Huber, S. A., A. Moraska, and M. Cunningham. 1994. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. USA 91:5543-5547.
17. + T-cell receptor. J. Virol. 70:3039-3044.
18. Huber, S. A., and B. Pfaeffle. 1994. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3. J. Virol. 68:5126-5132.
19. Huber, S. A., J. Polgar, P. Schultheiss, and P. Schwimmbeck. 1994. Augmentation of pathogenesis of coxsackievirus B3 infections in mice by exogenous administration of interleukin-1 and interleukin-2. J. Virol. 68:195-206.
20. Kandolf, R., A. Canu, and P. H. Hofschneider. 1985. Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell Cardiol. 17:167-181.
21. Kandolf, R., K. Klingel, H. Mertsching, A. Canu, C. Hohenadl, R. Zell, B. Y. Reimann, A. Heim, B. M. McManus, and A. K. Foulis. 1991. Molecular studies on enteroviral heart disease: patterns of acute and persistent infections. Eur. Heart J. 12(Suppl. D):49-55.
22. Klump, W. M., I. Bergmann, B. C. Muller, D. Ameis. and R. Kandolf. 1990. Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64:1573-1583.
23. Knowlton, K. U., E. Baracchini, R. S. Ross, A. N. Harris, S. A. Henderson, S. M, Evans, C. C. Glembotski, and K. R. Chien. 1991. Co-regulation of the atrial natriuretic factor and cardiac myosin light chain-2 genes during alpha-adrenergic stimulation of neonatal rat ventricular cells. Identification of cis sequences within an embryonic and a constitutive contractile protein gene which mediate induciblc expression. J. Biol. Chem. 266:7759-7768.
24. Knowlton, K. U., and E.-S. Jeon. Unpublished data.
25. Liljas, L., A. M. Lindberg, and U. Pettersson. 1993. Modelling of the tertiary structure of coxsackievirus B3 from the structure of poliovirus and rhinovirus. Scand. J. Infect. Dis. Suppl. 88:15-24.
26. Lindberg, A. M., R. L. Crowell, R. Zell, R. Kandolf, and U. Pettersson. 1992. Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res. 24:187-196.
27. Lindberg, A. M., P. O. Stalhandske, and U. Peltersson. 1987. Genome of coxsackievirus B3. Virology 156:50-63.
28. Loudon, R. P., A. F. Moraska, S. A. Huber, P. Schwimmbeck, and P. Schultheiss. 1991. An attenuated variant of coxsackievirus B3 preferentially induces immunoregulatory T cells in vivo. J. Virol. 65:5813-5819.
29. Macadam, A. J., D. M. Stone, J. W. Almond, and P. D. Minor. 1994. The 5′ noncoding region and virulence of poliovirus vaccine strains. Trends Microbiol. 2:449-454.
30. Minor, P. D., M. Ferguson, D. M. Evans, J. W. Almond, and J. P. Icenugle. 1986. Antigenic strueture of polioviruses of serotypes 1, 2, and 3. J. Gen. Virol. 67:1283-1291.
31. Murray, M. G., J. Bradley, X. F. Yang, E. Wimmer, E. G. Moss, and V. R. Racaniello. 1988. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site 1. Science 241:213-215.
32. Pearse, A. G. E. 1972. Histochemistry: theoretical and applied, p. 1138-1139. Williams & Wilkins, Baltimore.
33. Russmann, M. G., E. Arnold. J. W. Erickson, E. A. Frankenberger, J. P. Griffith, H. J. Hecht, J. E. Johnson, G. Kamer, M. Luo, and A. G. Mosser. 1985. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (London) 317:145-153.
34. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
35. Sherry, B., A. G. Mosser, R. J. Colonno, and R. R. Rueckert. 1986. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 57:245-257.
36. Sherry, B., and R. Rueckert. 1985. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J. Virol. 53:137-143.
37. Stanway, G., P. J. Hughes. R. C. Mountford, P. D. Minor, and J. W. Almond. 1984. The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res. 12:7859-7875.
38. Tormo, J., D. Blaas, N. R. Parry, D. Rowlands, D. Stuart, and I. Fita. 1994. Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBO J. 13:2247-2256.
39. Tracy, S., N. M. Chapman, and Z. Tu. 1992. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122:399-409.
40. Tu, Z., N. M. Chapman, G. Hufnagel, S. Tracy, J. R. Romero, W. H. Barry, L. Zhao, K. Currey, and B. Shapiro. 1995. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol. 69:4607-4618.
41. Ubertini, T. R., C. Cioni, L. Perini, and S. Gagnoni. 1988. Non-neurovirulent, genetically stable clone of poliovirus (Sabin type III vaccine strain). Vaccine 6:481-482.
42. Van Houten, N., P. E. Bouchard, A. Moraska, and S. A. Huber. 1991. Selection of an attenuated coxsackievirus B3 variant, using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65:1286-1290.
43. Weller, A. H., K. Simpson, M. Herzum, N. Van Hauten, and S. A. Huber. 1989. Coxsackievirus-B3-induced myocarditis: virus receptor antibodies modulate myocarditis. J. Immunol. 143:1843-1850.
44. Woodruff, J. F. 1980. Viral myocarditis. A review. Am. J. Pathol. 101:425-484.
45. Woodruff, J. F., and J. J. Woodruff. 1974. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J. Immunol. 113:1726-1734.
46. Yoneda, S., K. Senda, and K. Hayashi. 1979. Experimental study of virus myocarditis in culture. Jpn. Cire. J. 43:1048-1054.
47. Zhang, H., N. W. Blake, X. OuYang, Y. A. Pandolfino, P. Morgan-Capner, and L. C. Archard. 1995. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model. Arch. Virol. 140:959-966.
48. Zhang, H. Y., G. E. Yousef, L. Cunningham, N. W. Blake, X. OuYang, T. A. Bayston, K. Kandolf, and L. C. Archard. 1993. Attenuation of a reactivated cardiovirulent coxsackievirus B3: the 5′-nontranslated region does not contain major attenuation determinants. J. Med. Virol. 41:129-137.